First Page | Document Content | |
---|---|---|
Date: 2012-04-30 03:35:32Immunosuppressants Cell signaling Amgen Etanercept Drug design Drug action Rheumatoid arthritis Receptor Tumor necrosis factor receptor Biology Pharmacology Cell biology | CALIFORNIA STATE SCIENCE FAIR 2012 PROJECT SUMMARY Name(s) Project NumberAdd to Reading ListSource URL: www.usc.eduDownload Document from Source WebsiteFile Size: 14,09 KBShare Document on Facebook |
BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, biDocID: 1rrNB - View Document | |
July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first largescale acquisition since becoming a pureplay life sciences company, Bayer has raised its allcDocID: 1qiCw - View Document | |
TABLE OF CONTENTS INTRODUCTION 2DocID: 1qius - View Document | |
RHEUMATOLOGY Rheumatology 2011;50:iv5iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritisDocID: 1pLt5 - View Document | |
JUNE 2016 TABLE OF CONTENTS INTRODUCTIONDocID: 1pshE - View Document |